1. Home
  2. USNA vs PHAR Comparison

USNA vs PHAR Comparison

Compare USNA & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo USANA Health Sciences Inc.

USNA

USANA Health Sciences Inc.

HOLD

Current Price

$19.47

Market Cap

371.5M

Sector

Health Care

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$17.07

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USNA
PHAR
Founded
1992
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
371.5M
1.1B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
USNA
PHAR
Price
$19.47
$17.07
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$36.00
$38.00
AVG Volume (30 Days)
137.8K
27.8K
Earning Date
02-24-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.90
0.00
Revenue
$912,670,000.00
$362,274,000.00
Revenue This Year
$9.80
$25.19
Revenue Next Year
N/A
$4.47
P/E Ratio
$21.63
$3,081.99
Revenue Growth
5.88
26.78
52 Week Low
$18.48
$7.50
52 Week High
$38.32
$18.30

Technical Indicators

Market Signals
Indicator
USNA
PHAR
Relative Strength Index (RSI) 42.24 51.27
Support Level $19.44 $16.61
Resistance Level $19.98 $17.69
Average True Range (ATR) 0.49 0.79
MACD -0.03 -0.05
Stochastic Oscillator 11.38 42.82

Price Performance

Historical Comparison
USNA
PHAR

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: